KOSPI · Healthcare · ₩593B
₩40,150+0.63%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 10.5% · as of 26.10.27
Among 5 제약 peers
Quarterly Revenue Growth
“전문 영역의 처방 기반이 꾸준한 성장을 받쳐주는 흐름이에요.”
In the company's words · 2026 2분기 filing